Escend Pharmaceuticals, Inc.
3475 Edison Way
Suite R
Menlo Park
California
94025
United States
Tel: 650-241-9128
Website: http://www.escendpharma.com/
Email: info@escendpharma.com
About Escend Pharmaceuticals, Inc.
Escend Pharmaceuticals, Inc. , is developing therapeutics for cancer orphan indications. Our development focus includes therapeutics that kill cancer stem cells in chronic myelogenous leukemia and related hematologic malignancies.YEAR FOUNDED:
2014
LEADERSHIP:
Founder and CEO: Saira Bates
CLINICAL TRIAL:
Please click here for clinical trial information.
2 articles about Escend Pharmaceuticals, Inc.
-
Escend Pharmaceuticals, Inc., Receives IND Clearance from the FDA for ES-3000 Phase I Study in Relapsed or Refractory Acute Myeloid Leukemia (AML)
7/15/2022
Escend Pharmaceuticals, Inc., a privately held company focused on the development of small molecule therapeutics for oncology orphan diseases, announced that the United States Food and Drug Administration has cleared its investigational new drug application for its lead drug candidate, ES-3000 for a Phase I clinical trial in relapsed or refractory acute myeloid leukemia.
-
Escend Pharma Receives Second Orphan Drug Designation From FDA For ES-3000
12/28/2016